Welkom bij Scalda & Bohn Stafleu van Loghum
Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.
Gepubliceerd in:
26-11-2024
Developing a utility value set for the Gambling Quality of Life Scale-Brief (GQoLS-Brief) using a discrete choice experiment
Auteurs: Amandine Luquiens, Henri Panjo, Céline Bonnaire, Nathalie Pelletier-Fleury
Gepubliceerd in: Quality of Life Research | Uitgave 2/2025
Log in om toegang te krijgenshare
DELEN
Deel dit onderdeel of sectie (kopieer de link)
-
Optie A:
-
Optie B:Deel de link per e-mail
Abstract
Objectives
The Gambling Quality of Life Scale -brief (GQoLS-Brief) assesses the impact of gambling disorder (GD) on quality of life (QoL). Preference-based measures are essential for obtaining the quality adjustment weight (i.e. utility score) needed to calculate quality-adjusted life years (QALYs) in economic evaluations. We aimed to derive a value set for the GQoLS-Brief.
Methods
We employed a discrete choice experiment for preference elicitation. An online survey was administered (n = 928). Respondents completed 10 choice tasks, each presenting two GQoLS-Brief health states alongside life expectancy. Conditional logit regression, parameterized to fit the QALY framework, was used for data analysis. QALY weights for each health state defined by the GQoLS-Brief were calculated.
Results
The estimated coefficients from the conditional logit models aligned with expectations: utility increased with survival time and decreased with QoL impairment. Utility values for health states ranged from − 1.48 (worse than death) to 1.0. "Financial difficulties" exhibited the highest utility decrement, followed by "Sleep disturbance related to financial difficulties."
Conclusions
This reference set facilitates the calculation of QALYs for economic evaluations of GD interventions. The weight of subjective financial difficulties underscores the need for therapeutic interventions to target this aspect.
Log in om toegang te krijgen
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Mayo, N.E., ISOQOL Dictionary of Quality of Life and Health Outcomes Measurement. 2015: International Society for Quality of Life Research (ISOQOL).
Mayo, N.E., ISOQOL Dictionary of Quality of Life and Health Outcomes Measurement. 2015: International Society for Quality of Life Research (ISOQOL).
2.
go back to reference McHorney, C. A., Ware, J. E., Jr., & Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247–263.PubMedCrossRef
McHorney, C. A., Ware, J. E., Jr., & Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247–263.PubMedCrossRef
3.
go back to reference Luquiens, A., et al. (2015). Development of the Alcohol Quality of Life Scale (AQoLS): A new patient-reported outcome measure to assess health-related quality of life in alcohol use disorder. Quality of Life Research, 24(6), 1471–1481.PubMedCrossRef
Luquiens, A., et al. (2015). Development of the Alcohol Quality of Life Scale (AQoLS): A new patient-reported outcome measure to assess health-related quality of life in alcohol use disorder. Quality of Life Research, 24(6), 1471–1481.PubMedCrossRef
4.
go back to reference Luquiens, A., et al. (2016). Validation of a new patient-reported outcome instrument of health-related quality of life specific to patients with alcohol use disorder: The Alcohol Quality of Life Scale (AQoLS). Quality of Life Research, 25(6), 1549–1560.PubMedCrossRef
Luquiens, A., et al. (2016). Validation of a new patient-reported outcome instrument of health-related quality of life specific to patients with alcohol use disorder: The Alcohol Quality of Life Scale (AQoLS). Quality of Life Research, 25(6), 1549–1560.PubMedCrossRef
5.
go back to reference Dyer, A., et al. (2023). A systematic review of quality of life and health-related quality of life as outcomes in substance and behavioural addictions. Drug and Alcohol Review, 42(7), 1680–1700.PubMedCrossRef
Dyer, A., et al. (2023). A systematic review of quality of life and health-related quality of life as outcomes in substance and behavioural addictions. Drug and Alcohol Review, 42(7), 1680–1700.PubMedCrossRef
6.
go back to reference Pequeno, N. P. F., et al. (2020). Quality of life assessment instruments for adults: A systematic review of population-based studies. Health and Quality of Life Outcomes, 18(1), 208.PubMedPubMedCentralCrossRef
Pequeno, N. P. F., et al. (2020). Quality of life assessment instruments for adults: A systematic review of population-based studies. Health and Quality of Life Outcomes, 18(1), 208.PubMedPubMedCentralCrossRef
7.
go back to reference Phillips, C., What is a QALY? 2001.
Phillips, C., What is a QALY? 2001.
8.
go back to reference Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The basics. Value Health, 12(Suppl 1), S5-9.PubMedCrossRef
Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The basics. Value Health, 12(Suppl 1), S5-9.PubMedCrossRef
9.
go back to reference Whitehead, S. J., & Ali, S. (2010). Health outcomes in economic evaluation: The QALY and utilities. British Medical Bulletin, 96, 5–21.PubMedCrossRef
Whitehead, S. J., & Ali, S. (2010). Health outcomes in economic evaluation: The QALY and utilities. British Medical Bulletin, 96, 5–21.PubMedCrossRef
10.
go back to reference Kouakou, C. R. C., & Poder, T. G. (2022). Willingness to pay for a quality-adjusted life year: A systematic review with meta-regression. The European Journal of Health Economics, 23(2), 277–299.PubMedCrossRef
Kouakou, C. R. C., & Poder, T. G. (2022). Willingness to pay for a quality-adjusted life year: A systematic review with meta-regression. The European Journal of Health Economics, 23(2), 277–299.PubMedCrossRef
11.
go back to reference Van Wilder, L., et al. (2022). QALY losses for chronic diseases and its social distribution in the general population: Results from the Belgian Health Interview Survey. BMC Public Health, 22(1), 1304.PubMedPubMedCentralCrossRef
Van Wilder, L., et al. (2022). QALY losses for chronic diseases and its social distribution in the general population: Results from the Belgian Health Interview Survey. BMC Public Health, 22(1), 1304.PubMedPubMedCentralCrossRef
12.
go back to reference Jia, H., et al. (2018). Quality-adjusted Life Years (QALY) for 15 chronic conditions and combinations of conditions among US adults aged 65 and older. Medical Care, 56(8), 740–746.PubMedCrossRef
Jia, H., et al. (2018). Quality-adjusted Life Years (QALY) for 15 chronic conditions and combinations of conditions among US adults aged 65 and older. Medical Care, 56(8), 740–746.PubMedCrossRef
13.
go back to reference Brazier, J., et al. (2017). A review of generic preference-based measures for use in cost-effectiveness models. PharmacoEconomics, 35(Suppl 1), 21–31.PubMedCrossRef
Brazier, J., et al. (2017). A review of generic preference-based measures for use in cost-effectiveness models. PharmacoEconomics, 35(Suppl 1), 21–31.PubMedCrossRef
14.
go back to reference Comans, T. A., et al. (2018). Developing a dementia-specific preference–based quality of life measure (AD-5D) in Australia: A valuation study protocol. British Medical Journal Open, 8(1), e018996.
Comans, T. A., et al. (2018). Developing a dementia-specific preference–based quality of life measure (AD-5D) in Australia: A valuation study protocol. British Medical Journal Open, 8(1), e018996.
15.
go back to reference Jeanrenaud, C., et al., Le coût social du jeu excessif en Suisse. :. 2012, Institut de recherches économiques de l’Université de Neuchâtel.: Neuchâtel.
Jeanrenaud, C., et al., Le coût social du jeu excessif en Suisse. :. 2012, Institut de recherches économiques de l’Université de Neuchâtel.: Neuchâtel.
16.
go back to reference Magnusson, K., et al. (2019). Level of agreement between problem gamblers’ and collaterals’ reports: a bayesian random-effects two-part model. Journal of Gambling Studies, 35(4), 1127–1145.PubMedPubMedCentralCrossRef
Magnusson, K., et al. (2019). Level of agreement between problem gamblers’ and collaterals’ reports: a bayesian random-effects two-part model. Journal of Gambling Studies, 35(4), 1127–1145.PubMedPubMedCentralCrossRef
17.
go back to reference Walker, M., et al. (2006). A framework for reporting outcomes in problem gambling treatment research: The Banff. Alberta Consensus. Addiction, 101(4), 504–511.PubMed
Walker, M., et al. (2006). A framework for reporting outcomes in problem gambling treatment research: The Banff. Alberta Consensus. Addiction, 101(4), 504–511.PubMed
18.
go back to reference Pickering, D., et al. (2018). Measuring treatment outcomes in gambling disorders: A systematic review. Addiction, 113(3), 411–426.PubMedCrossRef
Pickering, D., et al. (2018). Measuring treatment outcomes in gambling disorders: A systematic review. Addiction, 113(3), 411–426.PubMedCrossRef
19.
go back to reference Mestre-Bach, G., & Potenza, M. N. (2023). Features linked to treatment outcomes in behavioral addictions and related disorders. International Journal of Environmental Research and Public Health, 20(4), 2873.PubMedPubMedCentralCrossRef
Mestre-Bach, G., & Potenza, M. N. (2023). Features linked to treatment outcomes in behavioral addictions and related disorders. International Journal of Environmental Research and Public Health, 20(4), 2873.PubMedPubMedCentralCrossRef
20.
go back to reference Braverman, J., Tom, M. A., & Shaffer, H. J. (2014). Accuracy of self-reported versus actual online gambling wins and losses. Psychological Assessment, 26(3), 865–877.PubMedCrossRef
Braverman, J., Tom, M. A., & Shaffer, H. J. (2014). Accuracy of self-reported versus actual online gambling wins and losses. Psychological Assessment, 26(3), 865–877.PubMedCrossRef
21.
go back to reference Dowling, N., et al. (2022). Pharmacological interventions for the treatment of disordered and problem gambling. Cochrane Database Systematic Review. https://doi.org/10.1002/14651858.CD008936.pub2CrossRef
Dowling, N., et al. (2022). Pharmacological interventions for the treatment of disordered and problem gambling. Cochrane Database Systematic Review. https://doi.org/10.1002/14651858.CD008936.pub2CrossRef
22.
go back to reference Moore, E., et al. (2024). The association between health-related quality of life and problem gambling severity: A cross-sectional analysis of the Health Survey for England. BMC Public Health, 24(1), 434.PubMedPubMedCentralCrossRef
Moore, E., et al. (2024). The association between health-related quality of life and problem gambling severity: A cross-sectional analysis of the Health Survey for England. BMC Public Health, 24(1), 434.PubMedPubMedCentralCrossRef
23.
go back to reference Kohler, D. (2014). A monetary valuation of the quality of life loss associated with pathological gambling: An application using a health utility index. Journal of gambling issues, 29, 1–23.CrossRef
Kohler, D. (2014). A monetary valuation of the quality of life loss associated with pathological gambling: An application using a health utility index. Journal of gambling issues, 29, 1–23.CrossRef
24.
go back to reference Moayeri, F. (2020). A reference set of Health State Utility Values for gambling problem behaviour, a survey of the Australian general population: Implications for future healthcare evaluations. Expert Review of Pharmacoeconomics & Outcomes Research, 20(1), 115–124.CrossRef
Moayeri, F. (2020). A reference set of Health State Utility Values for gambling problem behaviour, a survey of the Australian general population: Implications for future healthcare evaluations. Expert Review of Pharmacoeconomics & Outcomes Research, 20(1), 115–124.CrossRef
25.
go back to reference Bonfils, N. A., et al. (2019). Quality of life instruments used in problem gambling studies: A systematic review and a meta-analysis. Neuroscience and Biobehavioral Reviews, 104, 58–72.PubMedCrossRef
Bonfils, N. A., et al. (2019). Quality of life instruments used in problem gambling studies: A systematic review and a meta-analysis. Neuroscience and Biobehavioral Reviews, 104, 58–72.PubMedCrossRef
26.
go back to reference Browne, M., et al., Assessing gambling-related harm in Victoria: a public health perspective. 2016, Victorian Responsible Gambling Foundation, Melbourne.
Browne, M., et al., Assessing gambling-related harm in Victoria: a public health perspective. 2016, Victorian Responsible Gambling Foundation, Melbourne.
27.
go back to reference Rawat, V., et al. (2018). A tale of two countries: Comparing disability weights for gambling problems in New Zealand and Australia. Quality of Life Research, 27(9), 2361–2371.PubMedCrossRef
Rawat, V., et al. (2018). A tale of two countries: Comparing disability weights for gambling problems in New Zealand and Australia. Quality of Life Research, 27(9), 2361–2371.PubMedCrossRef
28.
go back to reference Browne, M., et al., The Gambling Harms Scales: Instruments to assess impact to gamblers and affected others that are benchmarked to health utility.. 2023, Victorian Responsible Gambling Foundation.
Browne, M., et al., The Gambling Harms Scales: Instruments to assess impact to gamblers and affected others that are benchmarked to health utility.. 2023, Victorian Responsible Gambling Foundation.
29.
go back to reference Langham, E., et al. (2016). Understanding gambling related harm: A proposed definition, conceptual framework, and taxonomy of harms. BMC Public Health, 16(1), 80.PubMedPubMedCentralCrossRef
Langham, E., et al. (2016). Understanding gambling related harm: A proposed definition, conceptual framework, and taxonomy of harms. BMC Public Health, 16(1), 80.PubMedPubMedCentralCrossRef
30.
go back to reference Browne, M., et al. (2022). Benchmarking gambling screens to health-state utility: The PGSI and the SGHS estimate similar levels of population gambling-harm. BMC Public Health, 22(1), 839.PubMedPubMedCentralCrossRef
Browne, M., et al. (2022). Benchmarking gambling screens to health-state utility: The PGSI and the SGHS estimate similar levels of population gambling-harm. BMC Public Health, 22(1), 839.PubMedPubMedCentralCrossRef
31.
go back to reference Ferris, J. and H. Wynne, The Canadian Problem Gambling Index: Final Report. 2001, CCSA.
Ferris, J. and H. Wynne, The Canadian Problem Gambling Index: Final Report. 2001, CCSA.
32.
go back to reference Svetieva, E., & Walker, M. (2008). Inconsistency between concept and measurement: The Canadian Problem Gambling Index (CPGI). Journal of Gambling Issues, 22, 157–173.CrossRef
Svetieva, E., & Walker, M. (2008). Inconsistency between concept and measurement: The Canadian Problem Gambling Index (CPGI). Journal of Gambling Issues, 22, 157–173.CrossRef
33.
go back to reference EMA, Reflection paper on the regulatory guidance for the use of health- Related quality of life (hrql) measures in the evaluation of Medicinal products 2005, Committee for medicinal products for human use: London.
EMA, Reflection paper on the regulatory guidance for the use of health- Related quality of life (hrql) measures in the evaluation of Medicinal products 2005, Committee for medicinal products for human use: London.
34.
go back to reference Bonfils, N. A., et al. (2022). Development and psychometric properties of a new patient-reported outcome instrument of health-related quality of life specific to patients with gambling disorder: The Gambling Quality of Life Scale (GQoLS). International Journal of Environmental Research and Public Health, 19(17), 10806.PubMedPubMedCentralCrossRef
Bonfils, N. A., et al. (2022). Development and psychometric properties of a new patient-reported outcome instrument of health-related quality of life specific to patients with gambling disorder: The Gambling Quality of Life Scale (GQoLS). International Journal of Environmental Research and Public Health, 19(17), 10806.PubMedPubMedCentralCrossRef
35.
go back to reference Arpinelli, F., & Bamfi, F. (2006). The FDA guidance for industry on PROs: The point of view of a pharmaceutical company. Health and Quality of Life Outcomes, 4, 85.PubMedPubMedCentralCrossRef
Arpinelli, F., & Bamfi, F. (2006). The FDA guidance for industry on PROs: The point of view of a pharmaceutical company. Health and Quality of Life Outcomes, 4, 85.PubMedPubMedCentralCrossRef
36.
go back to reference Bonfils, N. A., et al. (2019). Giving room to subjectivity in understanding and assessing problem gambling: A patient-centered approach focused on quality of life. Journal of Behavioral Addictions, 8, 103.PubMedPubMedCentralCrossRef
Bonfils, N. A., et al. (2019). Giving room to subjectivity in understanding and assessing problem gambling: A patient-centered approach focused on quality of life. Journal of Behavioral Addictions, 8, 103.PubMedPubMedCentralCrossRef
37.
go back to reference Flood, C., et al. (2018). What utility scores do mental health service users, healthcare professionals and members of the general public attribute to different health states? A co-produced mixed methods online survey. PLoS ONE, 13(10), e0205223.PubMedPubMedCentralCrossRef
Flood, C., et al. (2018). What utility scores do mental health service users, healthcare professionals and members of the general public attribute to different health states? A co-produced mixed methods online survey. PLoS ONE, 13(10), e0205223.PubMedPubMedCentralCrossRef
38.
go back to reference Ogorevc, M., et al. (2019). Questioning the differences between general public vs patient based preferences towards EQ-5D-5L defined hypothetical health states. Health Policy, 123(2), 166–172.PubMedCrossRef
Ogorevc, M., et al. (2019). Questioning the differences between general public vs patient based preferences towards EQ-5D-5L defined hypothetical health states. Health Policy, 123(2), 166–172.PubMedCrossRef
39.
go back to reference Doron Amsalem, M. D., et al. (2021). Sustained effect of a brief video in reducing public stigma toward individuals with psychosis: a randomized controlled trial of young adults. American Journal of Psychiatry, 178(7), 635–642.PubMedCrossRef
Doron Amsalem, M. D., et al. (2021). Sustained effect of a brief video in reducing public stigma toward individuals with psychosis: a randomized controlled trial of young adults. American Journal of Psychiatry, 178(7), 635–642.PubMedCrossRef
40.
go back to reference Xie, S., Wu, J., & Chen, G. (2022). Discrete choice experiment with duration versus time trade-off: A comparison of test-retest reliability of health utility elicitation approaches in SF-6Dv2 valuation. Quality of Life Research, 31(9), 2791–2803.PubMedCrossRef
Xie, S., Wu, J., & Chen, G. (2022). Discrete choice experiment with duration versus time trade-off: A comparison of test-retest reliability of health utility elicitation approaches in SF-6Dv2 valuation. Quality of Life Research, 31(9), 2791–2803.PubMedCrossRef
41.
go back to reference Street, D. J., et al. (2008). Designing Discrete Choice Experiments for Health Care. Using Discrete Choice Experiments to Value Health and Health Care (pp. 47–72). Dordrecht.CrossRef
Street, D. J., et al. (2008). Designing Discrete Choice Experiments for Health Care. Using Discrete Choice Experiments to Value Health and Health Care (pp. 47–72). Dordrecht.CrossRef
42.
go back to reference Kuhfeld, W.F., Marketing Research Methods in SAS. Experimental Design, Choice, Conjoint, and Graphical Techniques 2010.
Kuhfeld, W.F., Marketing Research Methods in SAS. Experimental Design, Choice, Conjoint, and Graphical Techniques 2010.
43.
go back to reference Jonker, M. F., et al. (2019). Attribute level overlap (and color coding) can reduce task complexity, improve choice consistency, and decrease the dropout rate in discrete choice experiments. Health Economics, 28(3), 350–363.PubMedCrossRef
Jonker, M. F., et al. (2019). Attribute level overlap (and color coding) can reduce task complexity, improve choice consistency, and decrease the dropout rate in discrete choice experiments. Health Economics, 28(3), 350–363.PubMedCrossRef
44.
go back to reference Kantar. Public Voice, le panel aléatoire de Kantar Public. 2023; Available from: https://www.kantarpublic.com/fr/expertise/solutions/public-voice-le-panel-aleatoire-de-kantar-public.
Kantar. Public Voice, le panel aléatoire de Kantar Public. 2023; Available from: https://www.kantarpublic.com/fr/expertise/solutions/public-voice-le-panel-aleatoire-de-kantar-public.
45.
go back to reference Xie, S., et al. (2020). Do discrete choice experiments approaches perform better than time trade-off in eliciting health state utilities? evidence from SF-6Dv2 in China. Value Health, 23(10), 1391–1399.PubMedCrossRef
Xie, S., et al. (2020). Do discrete choice experiments approaches perform better than time trade-off in eliciting health state utilities? evidence from SF-6Dv2 in China. Value Health, 23(10), 1391–1399.PubMedCrossRef
46.
go back to reference Devlin, N. J., et al. (2003). Logical inconsistencies in survey respondents’ health state valuations—a methodological challenge for estimating social tariffs. Health Economics, 12(7), 529–544.PubMedCrossRef
Devlin, N. J., et al. (2003). Logical inconsistencies in survey respondents’ health state valuations—a methodological challenge for estimating social tariffs. Health Economics, 12(7), 529–544.PubMedCrossRef
47.
go back to reference Bansback, N., et al. (2012). Using a discrete choice experiment to estimate health state utility values. Journal of Health Economics, 31(1), 306–318.PubMedCrossRef
Bansback, N., et al. (2012). Using a discrete choice experiment to estimate health state utility values. Journal of Health Economics, 31(1), 306–318.PubMedCrossRef
48.
go back to reference Curran, P. G. (2016). Methods for the detection of carelessly invalid responses in survey data. Journal of Experimental Social Psychology, 66, 4–19.CrossRef
Curran, P. G. (2016). Methods for the detection of carelessly invalid responses in survey data. Journal of Experimental Social Psychology, 66, 4–19.CrossRef
49.
go back to reference Dunn, A. M., et al. (2018). Intra-individual response variability as an indicator of insufficient effort responding: comparison to other indicators and relationships with individual differences. Journal of Business and Psychology, 33(1), 105–121.CrossRef
Dunn, A. M., et al. (2018). Intra-individual response variability as an indicator of insufficient effort responding: comparison to other indicators and relationships with individual differences. Journal of Business and Psychology, 33(1), 105–121.CrossRef
50.
go back to reference Meade, A., & Craig, B. (2012). Identifying careless responses in survey data. Psychological methods, 17, 437–455.PubMedCrossRef
Meade, A., & Craig, B. (2012). Identifying careless responses in survey data. Psychological methods, 17, 437–455.PubMedCrossRef
51.
go back to reference R_Core_Team. R: A Language and Environment for Statistical Computing. 2021; Available from: https://www.R-project.org/.
R_Core_Team. R: A Language and Environment for Statistical Computing. 2021; Available from: https://www.R-project.org/.
52.
go back to reference Norman, R., Cronin, P., & Viney, R. (2013). A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Applied Health Economics and Health Policy, 11(3), 287–298.PubMedCrossRef
Norman, R., Cronin, P., & Viney, R. (2013). A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Applied Health Economics and Health Policy, 11(3), 287–298.PubMedCrossRef
53.
go back to reference Gu, Y., Norman, R., & Viney, R. (2014). Estimating health state utility values from discrete choice experiments–a QALY space model approach. Health Economics, 23(9), 1098–1114.PubMedCrossRef
Gu, Y., Norman, R., & Viney, R. (2014). Estimating health state utility values from discrete choice experiments–a QALY space model approach. Health Economics, 23(9), 1098–1114.PubMedCrossRef
54.
go back to reference Viney, R., et al. (2014). An Australian discrete choice experiment to value eq-5d health states. Health Economics, 23(6), 729–742.PubMedCrossRef
Viney, R., et al. (2014). An Australian discrete choice experiment to value eq-5d health states. Health Economics, 23(6), 729–742.PubMedCrossRef
55.
go back to reference Bansback, N., et al. (2014). Testing a discrete choice experiment including duration to value health states for large descriptive systems: Addressing design and sampling issues. Social Science and Medicine, 114(100), 38–48.PubMedCrossRef
Bansback, N., et al. (2014). Testing a discrete choice experiment including duration to value health states for large descriptive systems: Addressing design and sampling issues. Social Science and Medicine, 114(100), 38–48.PubMedCrossRef
56.
go back to reference Norman, R., et al. (2014). Valuing SF-6D health states using a discrete choice experiment. Medical Decision Making, 34(6), 773–786.PubMedCrossRef
Norman, R., et al. (2014). Valuing SF-6D health states using a discrete choice experiment. Medical Decision Making, 34(6), 773–786.PubMedCrossRef
57.
go back to reference Norman, R., et al. (2016). Using a discrete choice experiment to value the QLU-C10D: Feasibility and sensitivity to presentation format. Quality of Life Research, 25(3), 637–649.PubMedCrossRef
Norman, R., et al. (2016). Using a discrete choice experiment to value the QLU-C10D: Feasibility and sensitivity to presentation format. Quality of Life Research, 25(3), 637–649.PubMedCrossRef
58.
go back to reference Mulhern, B., et al. (2017). Using discrete choice experiments with duration to model EQ-5D-5L health state preferences. Medical Decision Making, 37(3), 285–297.PubMedCrossRef
Mulhern, B., et al. (2017). Using discrete choice experiments with duration to model EQ-5D-5L health state preferences. Medical Decision Making, 37(3), 285–297.PubMedCrossRef
59.
go back to reference King, M. T., et al. (2018). Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30. PharmacoEconomics, 36(2), 225–238.PubMedCrossRef
King, M. T., et al. (2018). Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30. PharmacoEconomics, 36(2), 225–238.PubMedCrossRef
60.
go back to reference Jansen, F., et al. (2021). Dutch utility weights for the EORTC cancer-specific utility instrument: The Dutch EORTC QLU-C10D. Quality of Life Research, 30(7), 2009–2019.PubMedPubMedCentralCrossRef
Jansen, F., et al. (2021). Dutch utility weights for the EORTC cancer-specific utility instrument: The Dutch EORTC QLU-C10D. Quality of Life Research, 30(7), 2009–2019.PubMedPubMedCentralCrossRef
61.
go back to reference Nerich, V., et al. (2021). French Value-Set of the QLU-C10D, a cancer-specific utility measure derived from the QLQ-C30. Applied Health Economics and Health Policy, 19(2), 191–202.PubMedCrossRef
Nerich, V., et al. (2021). French Value-Set of the QLU-C10D, a cancer-specific utility measure derived from the QLQ-C30. Applied Health Economics and Health Policy, 19(2), 191–202.PubMedCrossRef
62.
go back to reference Ratcliffe, J., et al. (2022). Valuing the Quality-of-Life Aged Care Consumers (QOL-ACC) instrument for quality assessment and economic evaluation. PharmacoEconomics, 40(11), 1069–1079.PubMedPubMedCentralCrossRef
Ratcliffe, J., et al. (2022). Valuing the Quality-of-Life Aged Care Consumers (QOL-ACC) instrument for quality assessment and economic evaluation. PharmacoEconomics, 40(11), 1069–1079.PubMedPubMedCentralCrossRef
63.
go back to reference McTaggart-Cowan, H., et al. (2022). The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): A Canadian valuation study. Health and Quality of Life Outcomes, 20(1), 97.PubMedPubMedCentralCrossRef
McTaggart-Cowan, H., et al. (2022). The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): A Canadian valuation study. Health and Quality of Life Outcomes, 20(1), 97.PubMedPubMedCentralCrossRef
64.
go back to reference McFadden, D., Conditional logit analysis of qualitative choice behavior. Frontiers in econometrics, 1974.
McFadden, D., Conditional logit analysis of qualitative choice behavior. Frontiers in econometrics, 1974.
65.
go back to reference Bleichrodt, H., Wakker, P., & J. M. (1997). Characterizing QALYs by risk neutrality. Journal of Risk and Uncertainty, 15(2), 107–114.CrossRef
Bleichrodt, H., Wakker, P., & J. M. (1997). Characterizing QALYs by risk neutrality. Journal of Risk and Uncertainty, 15(2), 107–114.CrossRef
66.
go back to reference Bleichrodt, H., & Johannesson, M. (1997). The validity of QALYs: An experimental test of constant proportional tradeoff and utility independence. Medical Decision Making, 17(1), 21–32.PubMedCrossRef
Bleichrodt, H., & Johannesson, M. (1997). The validity of QALYs: An experimental test of constant proportional tradeoff and utility independence. Medical Decision Making, 17(1), 21–32.PubMedCrossRef
67.
go back to reference Bridges, J. F. P., et al. (2011). Conjoint analysis applications in health—a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value in Health, 14(4), 403–413.PubMedCrossRef
Bridges, J. F. P., et al. (2011). Conjoint analysis applications in health—a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value in Health, 14(4), 403–413.PubMedCrossRef
68.
go back to reference Oksanen, A., et al. (2018). Problem gambling and psychological distress: A cross-national perspective on the mediating effect of consumer debt and debt problems among emerging adults. Harm Reduction Journal, 15(1), 45.PubMedPubMedCentralCrossRef
Oksanen, A., et al. (2018). Problem gambling and psychological distress: A cross-national perspective on the mediating effect of consumer debt and debt problems among emerging adults. Harm Reduction Journal, 15(1), 45.PubMedPubMedCentralCrossRef
69.
go back to reference Muggleton, N., et al. (2021). The association between gambling and financial, social and health outcomes in big financial data. Nature Human Behaviour, 5(3), 319–326.PubMedCrossRef
Muggleton, N., et al. (2021). The association between gambling and financial, social and health outcomes in big financial data. Nature Human Behaviour, 5(3), 319–326.PubMedCrossRef
70.
go back to reference Karlsson, A., et al. (2021). Psychiatric comorbidity and economic hardship as risk factors for intentional self-harm in gambling disorder—a nationwide register study. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2021.688285CrossRefPubMedPubMedCentral
Karlsson, A., et al. (2021). Psychiatric comorbidity and economic hardship as risk factors for intentional self-harm in gambling disorder—a nationwide register study. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2021.688285CrossRefPubMedPubMedCentral
71.
go back to reference Lee, K., Kim, H., & Kim, Y. (2021). Gambling disorder symptoms, suicidal ideation, and suicide attempts. Psychiatry Investigation, 18(1), 88–93.PubMedPubMedCentralCrossRef
Lee, K., Kim, H., & Kim, Y. (2021). Gambling disorder symptoms, suicidal ideation, and suicide attempts. Psychiatry Investigation, 18(1), 88–93.PubMedPubMedCentralCrossRef
72.
go back to reference Vuorinen, I., et al. (2022). Basic psychological needs in gambling and gaming problems. Adaptive Human Behavior and Physiology, 16, 100445.
Vuorinen, I., et al. (2022). Basic psychological needs in gambling and gaming problems. Adaptive Human Behavior and Physiology, 16, 100445.
73.
go back to reference AmericanPsychiatricAssociation. Substance related and addictive disorders fact sheet. DSM5 organisation 2013; Available from: http://www.dsm5.org/Documents/Substance%20Use%20Disorder%20Fact%20Sheet.pdf.
AmericanPsychiatricAssociation. Substance related and addictive disorders fact sheet. DSM5 organisation 2013; Available from: http://www.dsm5.org/Documents/Substance%20Use%20Disorder%20Fact%20Sheet.pdf.
74.
go back to reference Chan, Y. H., et al. (2024). Targeting cravings in substance addiction with transcranial direct current stimulation: Insights from a meta-analysis of sham-controlled trials. Psychiatry Research, 331, 115621.PubMedCrossRef
Chan, Y. H., et al. (2024). Targeting cravings in substance addiction with transcranial direct current stimulation: Insights from a meta-analysis of sham-controlled trials. Psychiatry Research, 331, 115621.PubMedCrossRef
75.
go back to reference Grant, S., et al. (2017). Mindfulness-based Relapse Prevention for Substance Use Disorders: A Systematic Review and Meta-analysis. Journal of Addiction Medicine, 11(5), 386–396.PubMedPubMedCentralCrossRef
Grant, S., et al. (2017). Mindfulness-based Relapse Prevention for Substance Use Disorders: A Systematic Review and Meta-analysis. Journal of Addiction Medicine, 11(5), 386–396.PubMedPubMedCentralCrossRef
76.
go back to reference Hawker, C. O., et al. (2021). Exploring the associations between gambling cravings, self-efficacy, and gambling episodes: An Ecological Momentary Assessment study. Addictive Behaviors, 112, 106574.PubMedCrossRef
Hawker, C. O., et al. (2021). Exploring the associations between gambling cravings, self-efficacy, and gambling episodes: An Ecological Momentary Assessment study. Addictive Behaviors, 112, 106574.PubMedCrossRef
77.
go back to reference van Krugten, F. C. W., et al. (2024). Estimating a preference-based value set for the Mental Health Quality of Life Questionnaire (MHQoL). Medical Decision Making, 44(1), 64–75.PubMedCrossRef
van Krugten, F. C. W., et al. (2024). Estimating a preference-based value set for the Mental Health Quality of Life Questionnaire (MHQoL). Medical Decision Making, 44(1), 64–75.PubMedCrossRef
78.
go back to reference Konkoly Thege, B., et al. (2014). Social judgments of behavioral versus substance-related addictions: A population-based study. Addictive Behaviors, 42C, 24–31.
Konkoly Thege, B., et al. (2014). Social judgments of behavioral versus substance-related addictions: A population-based study. Addictive Behaviors, 42C, 24–31.
79.
go back to reference Brown, K., & Russell, A. (2020). What can be done to reduce the public stigma of gambling disorder? lessons from other stigmatised conditions. Journal of Gambling Studies, 36, 23.PubMedCrossRef
Brown, K., & Russell, A. (2020). What can be done to reduce the public stigma of gambling disorder? lessons from other stigmatised conditions. Journal of Gambling Studies, 36, 23.PubMedCrossRef
80.
go back to reference Roudijk, B., Donders, A. R. T., & Stalmeier, P. F. M. (2018). Setting dead at zero: applying scale properties to the QALY model. Medical Decision Making, 38(6), 627–634.PubMedPubMedCentralCrossRef
Roudijk, B., Donders, A. R. T., & Stalmeier, P. F. M. (2018). Setting dead at zero: applying scale properties to the QALY model. Medical Decision Making, 38(6), 627–634.PubMedPubMedCentralCrossRef
81.
go back to reference Mulhern, B., et al. (2019). One method, many methodological choices: a structured review of discrete-choice experiments for health state valuation. PharmacoEconomics, 37(1), 29–43.PubMedCrossRef
Mulhern, B., et al. (2019). One method, many methodological choices: a structured review of discrete-choice experiments for health state valuation. PharmacoEconomics, 37(1), 29–43.PubMedCrossRef
82.
go back to reference Lamers, L. (2007). The transformation of utilities for health states worse than death. Medical care, 45, 238–244.PubMedCrossRef
Lamers, L. (2007). The transformation of utilities for health states worse than death. Medical care, 45, 238–244.PubMedCrossRef
83.
go back to reference Gandhi, M., Rand, K., & Luo, N. (2019). Valuation of health states considered to be worse than death—an analysis of composite time trade-off data from 5 EQ-5D-5L valuation studies. Value in Health, 22(3), 370–376.PubMedCrossRef
Gandhi, M., Rand, K., & Luo, N. (2019). Valuation of health states considered to be worse than death—an analysis of composite time trade-off data from 5 EQ-5D-5L valuation studies. Value in Health, 22(3), 370–376.PubMedCrossRef
84.
go back to reference Stolk, E., et al. (2019). Overview, update, and lessons learned from the international EQ-5D-5L valuation work: Version 2 of the EQ-5D-5L valuation protocol. Value in Health, 22(1), 23–30.PubMedCrossRef
Stolk, E., et al. (2019). Overview, update, and lessons learned from the international EQ-5D-5L valuation work: Version 2 of the EQ-5D-5L valuation protocol. Value in Health, 22(1), 23–30.PubMedCrossRef
85.
go back to reference Shiroiwa, T., et al. (2024). Comparison of four value sets derived using different TTO and DCE approaches: Application to the new region-specific PBM, AP-7D. Health and Quality of Life Outcomes, 22(1), 16.PubMedPubMedCentralCrossRef
Shiroiwa, T., et al. (2024). Comparison of four value sets derived using different TTO and DCE approaches: Application to the new region-specific PBM, AP-7D. Health and Quality of Life Outcomes, 22(1), 16.PubMedPubMedCentralCrossRef
86.
go back to reference Balázs, P. G., et al. (2023). Time trade-off health state utility values for depression: A systematic review and meta-analysis. Quality of Life Research, 32(4), 923–937.PubMedCrossRef
Balázs, P. G., et al. (2023). Time trade-off health state utility values for depression: A systematic review and meta-analysis. Quality of Life Research, 32(4), 923–937.PubMedCrossRef
87.
go back to reference Hettiarachchi, R. M., et al. (2023). Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment. The European Journal of Health Economics, 24(8), 1285–1296.PubMedCrossRef
Hettiarachchi, R. M., et al. (2023). Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment. The European Journal of Health Economics, 24(8), 1285–1296.PubMedCrossRef
88.
go back to reference Schneider, P. (2022). The QALY is ableist: On the unethical implications of health states worse than dead. Quality of Life Research, 31(5), 1545–1552.PubMedCrossRef
Schneider, P. (2022). The QALY is ableist: On the unethical implications of health states worse than dead. Quality of Life Research, 31(5), 1545–1552.PubMedCrossRef
89.
go back to reference Bernfort, L., et al. (2018). People in states worse than dead according to the EQ-5D UK value set: Would they rather be dead? Quality of Life Research, 27(7), 1827–1833.PubMedPubMedCentralCrossRef
Bernfort, L., et al. (2018). People in states worse than dead according to the EQ-5D UK value set: Would they rather be dead? Quality of Life Research, 27(7), 1827–1833.PubMedPubMedCentralCrossRef
90.
go back to reference Drummond, M. F., et al. (2015). Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press.
Drummond, M. F., et al. (2015). Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press.
91.
go back to reference Jakubczyk, M., et al. (2024). This dead or that dead: framing effects in the evaluation of health states. Value Health, 27(1), 95–103.PubMedCrossRef
Jakubczyk, M., et al. (2024). This dead or that dead: framing effects in the evaluation of health states. Value Health, 27(1), 95–103.PubMedCrossRef
92.
go back to reference Costes, J., et al. (2020). Les Français et les jeux d’argent et de hasard Résultats du Baromètre de Santé publique France 2019. Tendances, 138, 6.
Costes, J., et al. (2020). Les Français et les jeux d’argent et de hasard Résultats du Baromètre de Santé publique France 2019. Tendances, 138, 6.
93.
go back to reference OFDT, Les jeux d'argent et de hasard en 2022, in note de bilan. 2023, OFDT: Paris. p. 9.
OFDT, Les jeux d'argent et de hasard en 2022, in note de bilan. 2023, OFDT: Paris. p. 9.
94.
go back to reference Pearce, A., et al. (2021). Respondent understanding in discrete choice experiments: a scoping review. Patient, 14(1), 17–53.PubMedCrossRef
Pearce, A., et al. (2021). Respondent understanding in discrete choice experiments: a scoping review. Patient, 14(1), 17–53.PubMedCrossRef
95.
go back to reference Mulhern, B., et al. (2018). How should discrete choice experiments with duration choice sets be presented for the valuation of health states? Medical Decision Making, 38(3), 306–318.PubMedCrossRef
Mulhern, B., et al. (2018). How should discrete choice experiments with duration choice sets be presented for the valuation of health states? Medical Decision Making, 38(3), 306–318.PubMedCrossRef
96.
go back to reference de Bekker-Grob, E. W., Ryan, M., & Gerard, K. (2012). Discrete choice experiments in health economics: A review of the literature. Health Economics, 21(2), 145–172.PubMedCrossRef
de Bekker-Grob, E. W., Ryan, M., & Gerard, K. (2012). Discrete choice experiments in health economics: A review of the literature. Health Economics, 21(2), 145–172.PubMedCrossRef
97.
go back to reference Augestad, L. A., et al. (2020). Using the choice sequence in time trade-off as discrete choices: do the two stories match? Value Health, 23(4), 487–494.PubMedCrossRef
Augestad, L. A., et al. (2020). Using the choice sequence in time trade-off as discrete choices: do the two stories match? Value Health, 23(4), 487–494.PubMedCrossRef
Metagegevens
- Titel
- Developing a utility value set for the Gambling Quality of Life Scale-Brief (GQoLS-Brief) using a discrete choice experiment
- Auteurs
-
Amandine Luquiens
Henri Panjo
Céline Bonnaire
Nathalie Pelletier-Fleury
- Publicatiedatum
- 26-11-2024
- Uitgeverij
- Springer New York
- Gepubliceerd in
-
Quality of Life Research
/ Uitgave 2/2025
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649 - DOI
- https://doi.org/10.1007/s11136-024-03835-5
